The current cost of 48-weeks of therapy is approximately US$35,000. Introduction of novel anti-HCV drugs that will be used in combination with PEG–IFN/ribavirin could double or even triple the ...

Figure 2: Sustained virological response rates with treatments for hepatitis C. As with HIV drug development, the first direct antivirals to be developed for HCV were the nucleoside analogues that ...

Harvoni and rival hep C drugs look set for approval in England – but NHS England may have the last word on controlling costs, finds Andrew McConaghie. Patients in England with hepatitis C (HCV ...

Discover top medications for 'treating Hepatitis C'? This page compiles essential information on generic and brand-name drugs specifically used for Hepatitis C treatment.Here, you can explore ...

It remains to be seen, however, how potent antiviral drug cocktails will affect the hepatitis C burden worldwide. In resource-poor environments, considerable costs, inadequate infrastructure for ...

It is plausible that the course and outcome of HCV many differ in those infected by injection drug use. Inoculum size and frequency of exposure may perturb the viral-host immune interaction.

For example, a phase 3 clinical trial of one recently-launched DAA in drug users on opioid substitution therapy found that cure rates were 91.5% – comparable to outcomes in the general HCV ...

Latest data show continued progress towards elimination of hepatitis C as a public health threat in England The UK Health ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.